165 related articles for article (PubMed ID: 37755537)
21. Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis.
Lee CM; Kang J
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1270-1282. PubMed ID: 32483936
[TBL] [Abstract][Full Text] [Related]
22. Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery.
West MA; van Dijk DPJ; Gleadowe F; Reeves T; Primrose JN; Abu Hilal M; Edwards MR; Jack S; Rensen SSS; Grocott MPW; Levett DZH; Olde Damink SWM
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):860-871. PubMed ID: 31115169
[TBL] [Abstract][Full Text] [Related]
23. Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study.
Bannangkoon K; Hongsakul K; Tubtawee T; Ina N; Chichareon P
Sci Rep; 2023 Mar; 13(1):3978. PubMed ID: 36894658
[TBL] [Abstract][Full Text] [Related]
24. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
[TBL] [Abstract][Full Text] [Related]
25. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
Nachit M; Horsmans Y; Summers RM; Leclercq IA; Pickhardt PJ
Radiology; 2023 Jun; 307(5):e222008. PubMed ID: 37191484
[TBL] [Abstract][Full Text] [Related]
26. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
[TBL] [Abstract][Full Text] [Related]
27. Combined impact of myosteatosis and liver steatosis on prognosis in stage I-III colorectal cancer patients.
Lee DH; Jo I; Lee HS; Kang J
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2908-2915. PubMed ID: 37964719
[TBL] [Abstract][Full Text] [Related]
28. A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients.
Nachit M; Lanthier N; Rodriguez J; Neyrinck AM; Cani PD; Bindels LB; Hiel S; Pachikian BD; Trefois P; Thissen JP; Delzenne NM
JHEP Rep; 2021 Aug; 3(4):100323. PubMed ID: 34355155
[TBL] [Abstract][Full Text] [Related]
29. Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer.
Yamashita S; Iguchi T; Koike H; Wakamiya T; Kikkawa K; Kohjimoto Y; Hara I
Int J Urol; 2021 Jul; 28(7):757-762. PubMed ID: 33821510
[TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China.
Zeng X; Shi ZW; Yu JJ; Wang LF; Sun CY; Luo YY; Shi PM; Lin Y; Chen YX; Guo J; Zhang CQ; Xie WF
Hepatol Int; 2024 Apr; 18(2):673-687. PubMed ID: 37332023
[TBL] [Abstract][Full Text] [Related]
31. Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study.
Morel A; Ouamri Y; Canouï-Poitrine F; Mulé S; Champy CM; Ingels A; Audard V; Luciani A; Grimbert P; Matignon M; Pigneur F; Stehlé T
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):386-396. PubMed ID: 34738343
[TBL] [Abstract][Full Text] [Related]
32. Influence of body composition profile on outcomes following colorectal cancer surgery.
Malietzis G; Currie AC; Athanasiou T; Johns N; Anyamene N; Glynne-Jones R; Kennedy RH; Fearon KC; Jenkins JT
Br J Surg; 2016 Apr; 103(5):572-80. PubMed ID: 26994716
[TBL] [Abstract][Full Text] [Related]
33. Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost.
Findlay M; Brown C; De Abreu Lourenço R; White K; Bauer J
J Hum Nutr Diet; 2020 Dec; 33(6):811-821. PubMed ID: 32609428
[TBL] [Abstract][Full Text] [Related]
34. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Yin C; Narumi A; Omura Y; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Kobayashi M; Araki T; McMillan DC; Miki C; Kusunoki M
JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1322-1333. PubMed ID: 29761898
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
36. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
[TBL] [Abstract][Full Text] [Related]
37. Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients.
Martin L; Gioulbasanis I; Senesse P; Baracos VE
JPEN J Parenter Enteral Nutr; 2020 Feb; 44(2):227-238. PubMed ID: 31012128
[TBL] [Abstract][Full Text] [Related]
38. Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT).
Chan DL; Clarke SJ; Engel A; Diakos CI; Pavlakis N; Roach PJ; Bailey DL; Bauer J; Findlay M
Eur J Clin Nutr; 2022 Jan; 76(1):143-149. PubMed ID: 33986486
[TBL] [Abstract][Full Text] [Related]
39. Skeletal muscle is prognostic in resected stage III malignant melanoma.
Youn S; Eurich DT; McCall M; Walker J; Smylie M; Sawyer MB
Clin Nutr; 2022 May; 41(5):1066-1072. PubMed ID: 35397311
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
Keyl J; Bucher A; Jungmann F; Hosch R; Ziller A; Armbruster R; Malkomes P; Reissig TM; Koitka S; Tzianopoulos I; Keyl P; Kostbade K; Albers D; Markus P; Treckmann J; Nassenstein K; Haubold J; Makowski M; Forsting M; Baba HA; Kasper S; Siveke JT; Nensa F; Schuler M; Kaissis G; Kleesiek J; Braren R
ESMO Open; 2024 Jan; 9(1):102219. PubMed ID: 38194881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
